International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012)

Author:

Storry J. R.1,Castilho L.2,Daniels G.3,Flegel W. A.4,Garratty G.5,de Haas M.6,Hyland C.7,Lomas-Francis C.8,Moulds J. M.9,Nogues N.10,Olsson M. L.11,Poole J.3,Reid M. E.8,Rouger P.12,van der Schoot E.4,Scott M.3,Tani Y.13,Yu L.-C.14,Wendel S.15,Westhoff C.8,Yahalom V.16,Zelinski T.17

Affiliation:

1. Clinical Immunology and Transfusion Medicine; University and Regional Laboratories; Lund Sweden

2. University of Campinas/Hemocentro; Campinas Brazil

3. Bristol Institute for Transfusion Sciences and IBGRL; NHSBT; Bristol UK

4. Clinical Center; Department of Transfusion Medicine; Bethesda MD USA

5. American Red Cross Blood Services; Pomona CA USA

6. Sanquin Blood Supply; Diagnostic Services; Amsterdam the Netherlands

7. Australian Red Cross Blood Services; Brisbane Australia

8. New York Blood Center; New York NY USA

9. LifeShare Blood Centers; Shreveport LA USA

10. Banc de Sang i Teixits; Barcelona Spain

11. Department of Laboratory Medicine; Division of Haematology and Transfusion Medicine; Lund University; Sweden

12. Centre national de Référence pour les Groupes sanguines; Paris France

13. Japanese Red Cross Kinki Block Blood Center; Ibaraki Japan

14. Mackay Memorial Hospital and National Taiwan University; Taipei Taiwan

15. Blood Bank; Hospital Sirio-Libanes; São Paulo Brazil

16. NBGRL Magen David Adom; Ramat Gan Israel

17. Rh Laboratory; Winnipeg Manitoba Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Reference29 articles.

1. A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome;Suchanowska;J Biol Chem,2012

2. An inherited RBC characteristic, NOR, resulting in erythrocyte polyagglutination;Harris;Vox Sang,1982

3. PARG: a new low prevalence RH blood group antigen;Scharberg;Vox Sang,2012

4. The “Anti-e” and antibody to a high-prevalence Rh antigen made by RHCE*ceMO/RHCE*cE and RHCE*ceMO/RHCE*ceMO people are not anti-hrS/anti-hrB nor anti-Hr/anti-HrB respectively;Peyrard;Transfusion,2010

5. KETI, a novel high incidence antigen in the Kell blood group system: a serological and molecular study;Karamatic Crew;Vox Sang,2011

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3